WASHINGTON, DC - JANUARY 20: Apple CEO Tim Cook (C) sits next to Donald Trump Jr at the inaugural ... [+] luncheon on January 20, 2025 in Washington, DC. Donald Trump takes office for his second ...

Imagine a world where woolly mammoths roam the tundra once more—not in a prehistoric dream but as a living, breathing reality. This isn’t science fiction; it’s cutting-edge science happening ...

Instead of dinosaurs, Colossal has set its sights on more recently lost species including the dodo, the thylacine — also known as the Tasmanian tiger– and the woolly mammoth. The last ...

She came out like a wooly mammoth and Dolly’s the best mum; a real pro. A better mummy you wouldn’t find.” To stay up to date with all the breaking news from major shows throughout 2025 ...

Woolly mammoths went extinct around 4,000 years ago, but scientists claim America will soon see the prehistoric animal in 2028. Colossal Biosciences, a Texas-based biotechnology and genetic ...

Apple (AAPL) closed at $237.87 in the latest trading session, marking a +1.97% move from the prior day. The stock's performance was ahead of the S&P 500's daily gain of 1.83%. Meanwhile, the Dow ...

Colossal Biosciences, the company that’s famously on a mission to bring back the woolly mammoth and two other extinct species, has raised a $200 million Series C at a $10.2 billion valuation ...

Digital rendering of the long-extinct woolly mammoth. Courtesy Colossal Biosciences The woolly mammoth could be brought back from extinction in just three years’ time—that is, if everything ...

(Bloomberg) -- A biotechnology startup working to bring back animals from extinction has raised $200 million at a valuation of $10.2 billion, more than six times its valuation just two years ago.

Learn More Colossal BioSciences has raised $200 million in a new round of funding to bring back extinct species like the woolly mammoth. Dallas- and Boston-based Colossal is making strides in the ...

No, this isn’t a new Jurassic Park plot: A real-life woolly mammoth could be on Earth by the decade’s end. Biotechnology start-up Colossal Biosciences Inc., which is using DNA and genomics in ...